← Back to the feed

Veraxa Biotech AG

History from 25 Jun 2025

UID

CHE-441.201.868

Legal form

AG

Canton

ZH

Founded

25 Jun 2025

Amount raised

not in the SHAB

Lead investor

not in the SHAB

Record

1. SHAB published 30 Jun 2025 · legal date 25 Jun 2025

   Company formed

   Founded 25 Jun 2025

   SHAB HR01-1006369252 ↗

2. SHAB published 10 Jun 2026 · legal date 27 Feb 2026

   Capital increase

   ●●○Likely financing

   Paid in cash

   Nominal capital

   100’000 → 1’248’634.11

   Shares

   100’000 → 141’407’813

   New shares, % of post-step shares

   — (nominal value per share changed)

   Das Aktienkapital wird infolge Fusion um CHF 1'147'904.00 erhöht. Aktienkapital neu: CHF 1'248'634.1103752759381898 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 1'248'634.1103752759381898 [bisher: CHF 100'000.00]. Aktien neu: 141'407'813 Namenaktien zu CHF 100/11325 [bisher: 100'000 Namenaktien zu CHF 1.00]. Die Gesellschaft hat mit Beschluss vom 27.02.2026 ein Kapitalband gemäss näherer Umschreibung in den Statuten beschlossen. Das Aktienkapital von CHF 100'000.00 wurde neu eingeteilt in 11'325'000 Namenaktien zu CHF 100/11'325. Das Aktienkapital beträgt richtig CHF 1'248'634 + 50/453.

   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.74 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006672232 ↗

3. SHAB published 10 Jun 2026 · legal date 27 Feb 2026

   Capital band adopted

   SHAB HR02-1006672232 ↗

4. SHAB published 10 Jun 2026 · legal date 27 Feb 2026

   Name changed

   Veraxa Biotech Holding AG → Veraxa Biotech AG

   SHAB HR02-1006672232 ↗

5. SHAB published 30 Jul 2026 · legal date 24 Jul 2026

   Capital band adopted

   SHAB HR02-1006719903 ↗

Published by 8 Oct 2026